U.S. Pharma Stock News

NYSE:ABM
NYSE:ABMCommercial Services

ABM Industries Deepens Chip Supply Chain Ties With WGNSTAR Deal

ABM Industries (NYSE:ABM) has completed its acquisition of WGNSTAR, a provider of services to semiconductor facilities. The deal expands ABM's footprint in semiconductor fabrication plants and related industrial sites tied to US chip and industrial supply chains. The acquisition will influence ABM's exposure to chip production facilities and data center related demand over time. ABM Industries is known for facility services across commercial, industrial and technology end markets. WGNSTAR...
NYSEAM:UMAC
NYSEAM:UMACElectronic

Unusual Machines (UMAC) Is Down 16.0% After Launching Lantronix Defense-Focused Drone AI Partnership - What's Changed

In March 2026, Lantronix Inc. and Unusual Machines, Inc. announced a collaboration to co-develop next-generation autonomous drone components that combine Lantronix’s edge AI compute with Unusual Machines’ mission-critical flight control systems, aimed at U.S. defense, public safety, and commercial use cases under the US$1.10 billion Drone Dominance Program. The partnership’s modular, upgradeable architecture and focus on trusted domestic supply chains could make Unusual Machines a more...
NYSE:KTB
NYSE:KTBLuxury

Lee And J Crew Tie Up Tests Kontoor Brands Premium Potential

Kontoor Brands' Lee, part of NYSE:KTB, has launched an exclusive collaboration with J.Crew. The collection reimagines Lee's legacy denim styles with a fresh take on American classics. The capsule uses premium materials and is available for men, women, and kids through Lee.com and J.Crew. This is the first Lee collaboration spanning all age groups on Lee.com, signaling a shift toward a more premium, fashion forward positioning. Kontoor Brands, the owner of Lee and Wrangler, operates in a...
NasdaqCM:LIND
NasdaqCM:LINDHospitality

How Lindblad’s Strong Revenue But Weak EPS At Lindblad Expeditions Holdings (LIND) Has Changed Its Investment Story

Earlier this week, Lindblad Expeditions reported a 23.3% year-on-year revenue increase and a strong EBITDA beat, but significantly missed analysts’ earnings-per-share estimates. This combination of robust top-line growth and weaker bottom-line performance has raised questions about how effectively the company is converting demand into sustainable profits. Next, we’ll explore how Lindblad’s strong revenue beat but weaker earnings performance could influence its investment narrative and future...
NasdaqCM:AHG
NasdaqCM:AHGHealthcare

Akso Health Group (AHG) Valuation Check As Shares Hit A New 52 Week High On Strong Revenue Growth

Akso Health Group (AHG) recently hit a new 52 week high at US$2.10, alongside reported 75.6% revenue growth and a 30% total return over the past year, despite a thin 1% gross margin. See our latest analysis for Akso Health Group. The latest move to US$2.42 comes after a strong run, with an 84.7% 1 month share price return and a 51.3% year to date share price return. The 1 year total shareholder return of 92.1% and very large 3 year total shareholder return suggest momentum has been building...
NYSE:RHLD
NYSE:RHLDProfessional Services

Assessing Resolute Holdings Management (RHLD) Valuation After Recent Share Price Pullback

Resolute Holdings Management (RHLD) has drawn fresh attention after recent trading left the stock with a 9% decline over the past month and a 24% decline over the past three months, sharpening focus on its valuation profile. See our latest analysis for Resolute Holdings Management. Despite the recent 30 day and 90 day share price returns of 8.6% and 24.6% declines, respectively, the 1 year total shareholder return of about 3.7x and the latest $164.17 share price point to fading short term...
NYSE:ARX
NYSE:ARXInsurance

Accelerant Holdings (ARX) Revenue Surges To US$326.9 Million Challenging Bearish Loss Narratives

Accelerant Holdings (ARX) closed FY 2025 with fourth quarter revenue of US$326.9 million and a basic EPS loss of US$0.0027, while the trailing twelve month figures showed revenue of US$912.9 million and a basic EPS loss of US$7.49. Over recent periods, the company has seen quarterly revenue move from US$181.2 million in Q4 2024 to US$163.5 million in Q1 2025, US$204.7 million in Q2 2025, US$217.8 million in Q3 2025 and US$326.9 million in Q4 2025, with EPS shifting from US$10.57 in Q4 2024 to...
NasdaqCM:LE
NasdaqCM:LESpecialty Retail

Lands' End (LE) Q4 EPS Rebound Tests Bullish Margin Expansion Narrative

Lands' End (LE) has rounded out FY 2026 with Q4 revenue of US$462.4 million and basic EPS of US$0.40, supported by net income of US$12.3 million. Over recent quarters, the company has seen revenue move from US$261.2 million in Q1 2026 to US$317.5 million in Q3 2026 before reaching US$462.4 million in Q4. Quarterly EPS shifted from a loss of US$0.27 in Q1 to a profit of US$0.40 in Q4. For investors, the focus now is on how sustainable these earnings are given the thin trailing net profit...
NasdaqGS:EQPT
NasdaqGS:EQPTTrade Distributors

EquipmentShare (EQPT) Margins Stay Thin As US$3m Profit Tests Bullish Growth Narratives

EquipmentShare.com (EQPT) just closed FY 2025 with fourth quarter revenue of US$1.6b and basic EPS of US$0.68. Trailing 12 month revenue came in at US$4.4b with basic EPS of US$0.04 as the business moved into positive net income territory of US$3m over that period. The company has seen quarterly revenue range from US$776.3m in 2024 Q3 to US$1.6b in 2025 Q4, with basic EPS swinging between a loss of US$0.30 in early 2025 and a profit of US$0.68 in the latest quarter. This leaves investors...
NasdaqCM:SSII
NasdaqCM:SSIIMedical Equipment

A Look At SS Innovations International (SSII) Valuation After Earnings And Auditor Going Concern Warning

SS Innovations International (SSII) drew investor attention after releasing its 2025 results, which combined higher reported revenue with a smaller annual net loss and, at the same time, a going concern warning from auditor BDO LLP. See our latest analysis for SS Innovations International. At a share price of US$5.01, SS Innovations International has seen a 25% 1 month share price return, while the year to date share price return and 1 year total shareholder return remain negative. This hints...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Alvotech (ALVO) TTM Profitability Challenged By Q4 US$108.5 Million Net Loss

FY 2025 earnings snapshot for Alvotech (NasdaqGM:ALVO) Alvotech (NasdaqGM:ALVO) closed FY 2025 with Q4 revenue of US$168.9 million and a basic EPS loss of US$0.44, as net income excluding extra items came in at a loss of US$108.5 million. The company has seen quarterly revenue range from US$102.99 million in Q3 2024 to US$173.3 million in Q2 2025, while basic EPS has swung between a loss of US$0.23 in Q4 2024 and a profit of US$0.39 in Q1 2025. This sets up a year where the trailing twelve...
NasdaqGM:TATT
NasdaqGM:TATTAerospace & Defense

TAT Technologies (TATT) Margin Expansion To 9.4% Tests Bullish Efficiency Narrative

TAT Technologies (NasdaqGM:TATT) has wrapped up FY 2025 with fourth quarter revenue of US$46.5 million and basic EPS of US$0.36, capping a year in which trailing 12 month revenue reached US$178.0 million and EPS came in at US$1.39. Over recent periods the company has seen quarterly revenue move from US$41.0 million in Q4 2024 to US$46.5 million in Q4 2025. Basic EPS was US$0.36 a year ago and US$0.36 this quarter on a quarterly basis, and moved from US$1.08 to US$1.39 on a trailing 12 month...
NasdaqGM:ASST
NasdaqGM:ASSTMedical Equipment

Strive Asset Management (ASST) Q4 US$205.6m Loss Reinforces Bearish Earnings Narratives

Strive Asset Management (ASST) FY 2025 earnings snapshot Strive Asset Management (ASST) has just wrapped up FY 2025 with Q4 total revenue of about US$1.3 million and a loss per share of US$6.17, alongside a net loss excluding extra items of US$205.6 million, setting a stark backdrop for the latest numbers. Over the past year, revenue has moved from roughly US$0.8 million in Q2 2024 to US$1.3 million in Q4 2025, while trailing twelve month EPS shifted from a US$194.99 loss to a US$12.74 loss...
NYSE:TRC
NYSE:TRCReal Estate

Tejon Ranch (TRC) Q4 Profitability Rebound Challenges Bearish Earnings Narratives

Tejon Ranch (TRC) has just wrapped up FY 2025 with fourth quarter revenue of US$21.1 million and basic EPS of US$0.06, while the full year on a trailing 12 month basis came in at US$49.6 million of revenue and essentially breakeven EPS around US$0.00. Over recent quarters, the company has seen revenue move from US$8.3 million and basic EPS of a US$0.06 loss in Q2 2025 to US$11.0 million and a US$0.06 loss in Q3 2024, before reaching Q4 2025’s US$21.1 million and US$0.06 EPS. This sets up a...
NYSE:ACN
NYSE:ACNIT

Accenture (ACN) Margin Slip To 10.6% Tests Bullish Earnings Narratives

Accenture (ACN) has reported Q2 2026 results with revenue of US$18.0b and basic EPS of US$2.96, setting the tone for how its consulting and technology services engine is currently translating into top and bottom line performance. The company has seen quarterly revenue move from US$16.7b in Q2 2025 to US$18.0b in Q2 2026, while basic EPS over the same quarters has shifted from US$2.85 to US$2.96, giving investors a clear read on how sales and earnings are tracking together. With a trailing net...
NYSE:MOV
NYSE:MOVLuxury

Movado Group (MOV) Margin Improvement Tests Bullish Earnings Narratives

Movado Group (MOV) has wrapped up FY 2026 with fourth quarter revenue of US$191.6 million and basic EPS of US$0.55, supported by trailing twelve month revenue of US$671.3 million and EPS of US$1.17, alongside a 44.6% earnings increase over the past year. Over recent quarters, the company has seen revenue move from US$174.7 million and EPS of US$0.30 in Q4 FY 2025 to US$191.6 million and EPS of US$0.55 in Q4 FY 2026. At the same time, trailing net profit margin has shifted from 2.8% to 4%,...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

Soleno Lawsuit Puts DCCR Safety Disclosures And Growth Story Under Scrutiny

A class action lawsuit has been filed against Soleno Therapeutics (NasdaqCM:SLNO) alleging failures to disclose significant safety concerns in clinical trials for its drug DCCR. The complaint targets the company and certain executives, claiming that undisclosed issues could affect DCCR's commercial prospects and Soleno's reputation. The case focuses on the period around the development and launch preparations of DCCR, Soleno's sole commercial product. Soleno Therapeutics is a biotech...
NasdaqGS:AVAH
NasdaqGS:AVAHHealthcare

Aveanna Healthcare Holdings (AVAH) Return To Profitability Tests Bearish Earnings Narratives

Aveanna Healthcare Holdings (AVAH) delivers full year 2025 results Aveanna Healthcare Holdings (AVAH) has wrapped up FY 2025 with fourth quarter revenue of US$662.5 million, basic EPS of US$0.85 and net income excluding extraordinary items of US$178.8 million. This frames a year where trailing twelve month revenue reached about US$2.4 billion and basic EPS was US$1.11. Over recent periods the company has seen revenue move from US$519.9 million in Q4 FY 2024 to US$662.5 million in Q4 FY 2025,...
NYSE:YRD
NYSE:YRDConsumer Finance

Yiren Digital FY 2025 Margin Collapse Challenges High Quality Earnings Narrative

Yiren Digital’s FY 2025 Results Put Margins Under the Microscope Yiren Digital (NYSE:YRD) has just closed out FY 2025 with fourth quarter revenue of C¥957.6 million and a loss per share of C¥10.12, as net income excluding extra items came in at a loss of C¥882.2 million against a C¥2.03 share price. The company has seen quarterly revenue range from C¥1,652.1 million in Q2 2025 to C¥1,452.2 million in Q4 2024. Basic EPS moved from a profit of C¥3.84 in Q4 2024 to a loss in the latest quarter,...
NasdaqGM:HYPR
NasdaqGM:HYPRMedical Equipment

Hyperfine (HYPR) Q4 Loss Improvement Tests Bullish Margin Narrative

Hyperfine (HYPR) closed out FY 2025 with Q4 revenue of US$5.3 million and a net loss of US$5.9 million, equal to a basic EPS loss of US$0.06. On a trailing twelve month basis it generated US$13.6 million of revenue and a total net loss of US$35.6 million, or a basic EPS loss of US$0.43. Over the past four reported quarters, revenue has moved from US$2.1 million in Q1 2025 to US$5.3 million in Q4 2025, while quarterly basic EPS losses ranged between US$0.06 and US$0.14 per share. This keeps...
NasdaqGS:LX
NasdaqGS:LXConsumer Finance

LexinFintech Holdings (NasdaqGS:LX) Margin Expansion Challenges Cautious Growth Narratives

LexinFintech Holdings (NasdaqGS:LX) FY 2025 earnings snapshot LexinFintech Holdings (NasdaqGS:LX) has wrapped up FY 2025 with fourth quarter revenue of C¥3,043.1 million and basic EPS of C¥1.27, capping a year where trailing twelve month revenue came in at C¥13.2 billion and EPS reached C¥9.90. Over the past few quarters the company has seen revenue move from C¥3,587.4 million in Q2 2025 to C¥3,417.5 million in Q3 2025 and then C¥3,043.1 million in Q4 2025, while quarterly EPS shifted from...
NasdaqCM:OSS
NasdaqCM:OSSTech

One Stop Systems (OSS) Swings To Q3 Profit Challenging Longstanding Loss Narrative

One Stop Systems (OSS) has put up a mixed FY 2025 scorecard so far, with Q3 revenue of about US$18.8 million and basic EPS of roughly US$0.01, alongside trailing 12 month revenue of about US$60.3 million and a loss of roughly US$6.9 million on a basic EPS basis of about US$0.32. The company has seen quarterly revenue move from about US$13.2 million in Q2 2024 to US$15.1 million in Q4 2024, then to US$12.3 million in Q1 2025, US$14.1 million in Q2 2025 and US$18.8 million in Q3 2025. Basic EPS...
NYSE:NSA
NYSE:NSASpecialized REITs

Is It Time To Reassess National Storage Affiliates (NSA) After Its Recent Share Price Surge

Many investors may be wondering if National Storage Affiliates Trust is priced fairly or offering value right now, especially after its recent run in the market. The stock last closed at US$38.84, with returns of 25.5% over 7 days, 14.0% over 30 days, 39.3% year to date, 8.8% over 1 year, 21.2% over 3 years and 28.3% over 5 years, figures that many investors will want to put into context. Recent coverage has focused on how National Storage Affiliates Trust fits into the broader self storage...